Absolute Return Capital’s QIAGEN NV QGENF Stock Holding History

Absolute Return Capital’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-5,498	Closed	-$142K	–	496
2015 Q3	$142K	Sell	5,498 -11,645	-68%	-$301K	0.01%	457
2015 Q2	$425K	Buy	+17,143	New	+$425K	0.02%	438
2014 Q3	–	Sell	-4,572	Closed	-$112K	–	1268
2014 Q2	$112K	Buy	+4,572	New	+$112K	﹤0.01%	1107
2013 Q4	–	Sell	-147,672	Closed	-$3.16M	–	785
2013 Q3	$3.16M	Sell	147,672 -69,681	-32%	-$1.49M	0.04%	413
2013 Q2	$4.33M	Buy	+217,353	New	+$4.33M	0.06%	387

Other funds holding QGENF

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

Credit Agricole Montrouge Cedex, France $38.1B AUM

Absolute Return Capital's QGENF Position: Q4 2015 in Review

Absolute Return Capital sold out of QIAGEN NV (QGENF) in Q4 2015, closing a stake of 5,498 shares — an estimated $142K sold.

Absolute Return Capital first reported a position in QGENF in Q2 2013 and held it in 5 quarters. The position peaked at $4.33M in Q2 2013. 191 funds tracked by Wall St. Rank hold QGENF as of Q4 2015.

Absolute Return Capital reported no remaining QIAGEN NV position as of Q4 2015 after selling out during the quarter.
Absolute Return Capital sold 5,498 QIAGEN NV shares in Q4 2015, an estimated $142K.
Absolute Return Capital first reported a position in QIAGEN NV in Q2 2013 and held it in 5 quarters.
Absolute Return Capital's QIAGEN NV position peaked at $4.33M in Q2 2013.
191 funds tracked by Wall St. Rank held QIAGEN NV as of Q4 2015.

Based on Absolute Return Capital's 13F filing for Q4 2015.